HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Quote:
Login Free Membership
Search:

Best Performing ETFs  

Top 3 Best Performing Healthcare ETFs

Share
By: William Meade
November 02, 2011 | Comment(s): 0
Recommended this article (6)
BBH | IHE | XLV

When markets are facing a downturn, investors often depend on the healthcare sector to safeguard their investments. Since the demand for healthcare and related services does not fluctuate with changing market conditions, such investments are a safe haven during tough times. Many pharmaceutical companies also pay out regular dividends, which soften the blow investors receive from falling share prices. ETFs are the perfect choice for investors looking to enter this sector since they posses the advantages of analytical insight gleaned form in depth research which is needed to keep abreast of the latest advancements in this domain.

Exchange Traded Fund YTD Performance
Biotech HOLDRS 7.93%
ishares Dow Jones US Pharmaceuticals 5.86%
Pharmaceutical HOLDRS 3.73%

Biotech HOLDRS (BHH) - is comprised of 18 companies involved in the Biotech Sector. This ETF has a below average expense ratio of 0.42%. The largest holdings in the ETF are Amgen, Biogen and Gilead Sciences.

ishares Dow Jones US Pharmaceuticals (IHE) - seeks to replicate generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Pharmaceuticals Index. This ETF has a below average expense ratio of 0.47% and has net assets $192.2 million.

Pharmaceutical HOLDRS (PPH) - is comprised of 21 diversified companies in the pharmaceutical sector.  This ETF has an expense ratio of 0.42% below the category average. The largest holdings in this ETF are Johnson&Johnson, Pfizer and Merck.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 15:57 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center